FFCP PHASE1:Hg19::chr11:83463186..83463229,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(6 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |HGNC=NA | ||
|TSSclassifier=strong | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr11:83463186..83463229,- | |||
|coexpression_cluster_id=C63 | |coexpression_cluster_id=C63 | ||
|description=CAGE_peak_at_chr11:83463186..83463229,- | |description=CAGE_peak_at_chr11:83463186..83463229,- | ||
|id=chr11:83463186..83463229,- | |id=chr11:83463186..83463229,- | ||
|ontology_enrichment_celltype=CL:0000333;3.00e-40;5!CL:0002321;3.04e-14;15 | |ontology_enrichment_celltype= | ||
| | |ontology_enrichment_celltype_v019=CL:0000333;3.00e-40;5!CL:0002321;3.04e-14;15 | ||
|ontology_enrichment_disease=DOID:171;4.50e-45;10!DOID:169;9.08e-34;6!DOID:3193;8.10e-26;2!DOID:962;8.10e-26;2!DOID:3095;4.13e-21;22!DOID:2994;4.13e-21;22!DOID:1192;1.03e-17;3 | |ontology_enrichment_celltype_v019_2= | ||
|ontology_enrichment_uberon=UBERON:0000013;3.00e-40;5!UBERON:0002410;3.00e-40;5!UBERON:0003714;8.10e-26;2!UBERON:0000010;6.07e-23;8!UBERON:0002346;8.82e-14;4!UBERON:0000923;8.82e-14;4!UBERON:0010316;8.82e-14;4!UBERON:0005291;8.82e-14;4!UBERON:0002050;2.66e-11;5!UBERON:0005423;2.66e-11;5 | |ontology_enrichment_development_v019= | ||
|ontology_enrichment_disease=DOID:171!2.37e-70!10;DOID:3095!2.47e-32!22;DOID:2994!2.47e-32!22;DOID:169!6.48e-20!6;DOID:3193!1.78e-15!2;DOID:962!1.78e-15!2;DOID:1192!8.99e-11!3 | |||
|ontology_enrichment_disease_v019=DOID:171;4.50e-45;10!DOID:169;9.08e-34;6!DOID:3193;8.10e-26;2!DOID:962;8.10e-26;2!DOID:3095;4.13e-21;22!DOID:2994;4.13e-21;22!DOID:1192;1.03e-17;3 | |||
|ontology_enrichment_disease_v019_2=DOID:171,4.85e-45,10;DOID:169,9.87e-34,6;DOID:3193,9.18e-26,2;DOID:962,9.18e-26,2;DOID:3095,4.27e-21,22;DOID:2994,4.27e-21,22;DOID:1192,1.12e-17,3 | |||
|ontology_enrichment_uberon=UBERON:0000013!1.14e-23!5;UBERON:0002410!1.14e-23!5;UBERON:0003714!1.78e-15!2;UBERON:0000010!1.23e-13!8 | |||
|ontology_enrichment_uberon_v019=UBERON:0000013;3.00e-40;5!UBERON:0002410;3.00e-40;5!UBERON:0003714;8.10e-26;2!UBERON:0000010;6.07e-23;8!UBERON:0002346;8.82e-14;4!UBERON:0000923;8.82e-14;4!UBERON:0010316;8.82e-14;4!UBERON:0005291;8.82e-14;4!UBERON:0002050;2.66e-11;5!UBERON:0005423;2.66e-11;5 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000013,3.31e-40,5;UBERON:0002410,3.31e-40,5;UBERON:0003714,9.18e-26,2;UBERON:0000010,6.41e-23,8 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.74962768029953,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.67352101155024,0,0,0.637724760305049,16.2355851179293,1.11728983594649,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.175871244359621,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.730336388246517,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.74962768029953,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.67352101155024,0,0,0.637724760305049,16.2355851179293,1.11728983594649,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.175871244359621,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.730336388246517,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr11:83463186..83463229,- | |short_description=p@chr11:83463186..83463229,- | ||
}} | }} |
Latest revision as of 03:06, 24 July 2015
Short description: | p@chr11:83463186..83463229, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr11:83463186..83463229, - |
Coexpression cluster: | C63_neuroectodermal_neuroblastoma_carcinoid_peripheral_chronic_neuroepithelioma_acute |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
sympathetic nervous system | 3.31e-40 | 5 |
autonomic nervous system | 3.31e-40 | 5 |
neural tissue | 9.18e-26 | 2 |
peripheral nervous system | 6.41e-23 | 8 |
Ontology term | p-value | n |
---|---|---|
neuroectodermal tumor | 4.85e-45 | 10 |
neuroendocrine tumor | 9.87e-34 | 6 |
peripheral nerve sheath neoplasm | 9.18e-26 | 2 |
neurofibroma | 9.18e-26 | 2 |
germ cell and embryonal cancer | 4.27e-21 | 22 |
germ cell cancer | 4.27e-21 | 22 |
peripheral nervous system neoplasm | 1.12e-17 | 3 |